首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1304228

癌症化疗诱发性噁心及呕吐治疗药市场:各类型，各药物类别，各给药途径，各流通管道，各地区:规模，占有率，展望，机会分析，2023～2030年

Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Type, By Drug Class, By Route of Administration, By Distribution Channel, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: 2023年06月13日 | 出版商:

Coherent Market Insights | 英文 266 Pages | 商品交期: 2-3个工作天内

价格

简介目录

市场动态

化疗引起的噁心和呕吐（CINV）药物用于接受化疗的患者，以预防噁心和呕吐。接受化疗的患者数量的增加预计将在预测期内推动市场增长。

本调查的主要特征

本报告提供以2021年为基准年的预测期间（2022-2030 年）之全球癌症化疗诱发性噁心及呕吐治疗药市场的市场规模和復合年增长率（CAGR %）相关的详细分析。
并阐明不同部门市场的潜在收入机会，说明该市场具有魅力的投资主张矩阵。
同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
并基于企业亮点，各类型投资组合、主要焦点、财务业绩和市场策略等参数，介绍全球癌症化疗诱发性噁心及呕吐治疗药市场的主要参与者之企业简介。
藉由该报告提供的洞察，将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
全球癌症化疗诱发性噁心及呕吐治疗药市场报告配合该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
利益相关者可以透过全球癌症化疗诱发性噁心及呕吐治疗药市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

Eisai Co., Ltd.
Pharmanovia
Novartis AG
Merck & Co., Inc.
Helsinn Healthcare SA
Reddy's Laboratories Ltd.
Validus Pharmaceuticals LLC
LGM Pharma
Astellas Pharma Inc.
AdvaCare Pharma
Norgine
PV Pharma
Fresenius Kabi
Lupin
Hetero Healthcare Limited.
Sino Biopharmaceutical Limited
Glenmark Pharmaceuticals Ltd.
Otsuka Pharmaceutical Co., Ltd
OPKO Health, Inc.
Weefsel Pharma
Pfizer Inc.
Rosemont Pharmaceuticals Ltd.
Starton Therapeutics

第11章章节

调查手法
关于出版社

简介目录

Product Code: CMI5823

Treatment for cancer patients must prioritize preventing and controlling nausea and vomiting (N&V). One of the most prevalent and upsetting acute adverse effects of chemotherapy-induced nausea and vomiting (N&V) is cancer treatment. It can significantly lower a patient's quality of life and happens in up to 80% of patients. The perceptual feeling of nausea is an unpleasant, wave-like sensation in the epigastrium and/or back of the throat that may lead to vomiting (emesis). Emesis, the violent evacuation of stomach, duodenal, or jejunal contents through the oral canal, is referred to as vomiting. Retching, also known as dry heaves, involves the stomach and esophageal motions of vomiting without the evacuation of vomitus. Understanding the neurophysiological systems that regulate nausea and vomiting (N&V) has advanced. The central nervous system regulates or mediates both, but through different ways. The autonomic nervous system is the mechanism that causes nausea.

A complicated response that includes the convergence of afferent input is stimulated during vomiting. Neurotransmitters in the chemoreceptor trigger zone, the vomiting center (said to be situated in the nucleus tractus solitarius), and enterochromaffin cells in the gastrointestinal tract emit efferent impulses. These neurotransmitters include serotonin, substance P, and dopamine. These signals are sent to the respiratory center, salivation center, and abdominal muscles. The relative importance of these several routes, which result in N&V symptoms, is complicated. It is proposed to explain agents' varying emetogenicity (intrinsic emetogenicity and mitigating variables [i.e., dose, administration method, and exposure length]) and emetogenic profile (i.e., time to onset, intensity, and duration of symptoms).

Market Dynamics

Chemotherapy-induced nausea and vomiting (CINV) drugs are given to patients who undergo chemotherapy treatment to prevent nausea and vomiting. An increase in the number of patients undergoing chemotherapy is expected to drive the market growth over the forecast period. For instance, according to the data provided by the Centers for Disease Control and Prevention, in November 2022, more than 1 million cancer patients receive chemotherapy or radiation in an outpatient oncology clinic in the U.S. each year.

Key features of the study:

This report provides an in-depth analysis of the global cancer chemotherapy associated nausea and vomiting therapeutics market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cancer chemotherapy associated nausea and vomiting therapeutics market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Eisai Co., Ltd., Pharmanovia, Novartis AG, Merck & Co., Inc., Helsinn Healthcare SA, Dr. Reddy's Laboratories Ltd., Validus Pharmaceuticals LLC, LGM Pharma, Astellas Pharma Inc., AdvaCare Pharma, Norgine, PV Pharma, Fresenius Kabi, Lupin, Hetero Healthcare Limited., Sino Biopharmaceutical Limited, Glenmark Pharmaceuticals Ltd., Otsuka Pharmaceutical Co., Ltd, OPKO Health, Inc., Weefsel Pharma, Pfizer Inc., Rosemont Pharmaceuticals Ltd., Starton Therapeutics.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global cancer chemotherapy associated nausea and vomiting therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer chemotherapy associated nausea and vomiting therapeutics market

Detailed Segmentation:

Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Type:
- Acute CINV
- Delayed CINV
- Anticipatory nausea and emesis
- Breakthrough CINV/Refractory CINV
Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Drug Class:
- Dopamine Receptor Antagonists
  - Metoclopramide
  - Chlorpromazine
  - Prochlorperazine
  - Haloperidol
  - Droperidol
  - Others
- Serotonin (5-HT3) receptor Antagonists
  - Ondansetron
  - Granisetron
  - Palonosetron
  - Dolasetron
  - Others
- Substance P/NK-1 Antagonists
  - Aprepitant
  - Fosaprepitant
  - Netupitant
  - Others
- Corticosteroids
  - Dexamethasone
  - Methylprednisolone
- Others
Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Route of Administration:
- Oral
- Parenteral
- Transdermal Patch
Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Region:
- North America
  - By Country
- U.S.
- Canada
- Latin America
  - By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country/Regions
- South Africa
- Central Africa
- North Africa
Company Profiles
- Eisai Co., Ltd.*
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Pharmanovia
- Novartis AG
- Merck & Co., Inc.
- Helsinn Healthcare SA
- Reddy's Laboratories Ltd.
- Validus Pharmaceuticals LLC
- LGM Pharma
- Astellas Pharma Inc.
- AdvaCare Pharma
- Norgine
- PV Pharma
- Fresenius Kabi
- Lupin
- Hetero Healthcare Limited.
- Sino Biopharmaceutical Limited
- Glenmark Pharmaceuticals Ltd.
- Otsuka Pharmaceutical Co., Ltd
- OPKO Health, Inc.
- Weefsel Pharma
- Pfizer Inc.
- Rosemont Pharmaceuticals Ltd.
- Starton Therapeutics.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Drug Class
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Key Developments
PEST Analysis
PORTER's Analysis
Regulatory Scenario
Merger, Collaboration and Acquisition Scenario
Product Launches/Approvals
Epidemiology

4. Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market- COVID-19 Impact Analysis

Economic Impact
Overall Impact on Healthcare Sector
COVID-19 Epidemiology

5. Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Type, 2018 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Acute CINV
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Delayed CINV
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Anticipatory nausea and emesis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Breakthrough CINV/Refractory CINV
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

6. Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Drug Class, 2018 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Dopamine Receptor Antagonists
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Metoclopramide
Chlorpromazine
Prochlorperazine
Haloperidol
Droperidol
Others
Serotonin (5-HT3) receptor Antagonists
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Ondansetron
Granisetron
Palonosetron
Dolasetron
Others
Substance P/NK-1 Antagonists
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Aprepitant
Fosaprepitant
Netupitant
Others
Corticosteroids
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Dexamethasone
Methylprednisolone
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

7. Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Route of Administration, 2018 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Parenteral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Transdermal Patch
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

8. Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Distribution Channel, 2018 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

9. Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Region, 2018 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2018-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
UK
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
North Africa
Central Africa
South Africa

10. Competitive Landscape

Eisai Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pharmanovia
Novartis AG
Merck & Co., Inc.
Helsinn Healthcare SA
Reddy's Laboratories Ltd.
Validus Pharmaceuticals LLC
LGM Pharma
Astellas Pharma Inc.
AdvaCare Pharma
Norgine
PV Pharma
Fresenius Kabi
Lupin
Hetero Healthcare Limited.
Sino Biopharmaceutical Limited
Glenmark Pharmaceuticals Ltd.
Otsuka Pharmaceutical Co., Ltd
OPKO Health, Inc.
Weefsel Pharma
Pfizer Inc.
Rosemont Pharmaceuticals Ltd.
Starton Therapeutics

11. Section

Research Methodology
About Us

02-2729-4219

+886-2-2729-4219

License/价格

癌症化疗诱发性噁心及呕吐治疗药市场:各类型，各药物类别，各给药途径，各流通管道，各地区:规模，占有率，展望，机会分析，2023～2030年